Arthrosamid Injection Reviews & UK Patient Stories

Key Takeaways

• Arthrosamid is a hydrogel injection that provides long-lasting relief for knee osteoarthritis, with most patients experiencing significant improvement.

• Clinical data shows patients can experience benefits within 4 weeks, with improvements lasting up to 3 years and success rates of 50-100% at the 4-month mark.

• The treatment combines unique PAAG hydrogel technology (2.5% polyacrylamide, 97.5% water) with 20 years of safety data and 3 years of human clinical trials.

• MSK Doctors provides expert Arthrosamid treatment with comprehensive support, advanced technology, and personalized care plans for optimal outcomes.

• Patient reviews are overwhelmingly positive, with success stories including anyone from GPs to Olympic athletes.

Arthrosamid Injection Overview

Arthrosamid is primarily used for knee osteoarthritis, a degenerative joint disease that causes cartilage and bone breakdown in the knee. This condition leads to pain, stiffness, and reduced mobility, significantly impacting the quality of life. 

Arthrosamid injections have emerged as a promising treatment for individuals suffering from knee osteoarthritis, offering a new avenue for pain relief and improved joint function. 

This treatment option involves injecting a hydrogel directly into the knee joint, providing cushioning and long-term pain relief. 

Unlike traditional steroid injections, which offer only temporary relief by reducing inflammation, Arthrosamid aims to deliver sustained comfort by enhancing the joint's function.

The procedure is quick, minimally invasive, and a preferable alternative to more extensive surgeries. Most patients begin to feel relief within a few weeks, with gradual improvements as the hydrogel works to reduce inflammation and enhance joint function.

Expert Insights 

Clinical research led by internationally acclaimed rheumatologist Professor Henning Bliddal and the team at Contura Orthopaedics has demonstrated significant success with Arthrosamid treatments. 

The prospective, peer-reviewed studies show consistent positive outcomes, with patients maintaining statistically significant pain reduction up to three years after treatment. 

These findings have been presented at the Osteoarthritis Research Society International (OARSI) World Congress and published in reputable medical journals, helping establish Arthrosamid as a promising option in the field of knee osteoarthritis management.

Professor Paul Lee, Consultant Orthopaedic Surgeon and specialist in Sports and Regenerative Medicine, has pioneered Arthrosamid treatment in the UK. 

"I was the first doctor in the UK to use Arthrosamid injections to treat patients with knee pain. I have now treated over 100 knees and our results are similar to those seen in clinical trials, which is very reassuring," explains Professor Lee. Through his extensive experience, he has developed specific protocols to help patients achieve optimal results from their injections.

The treatment's efficacy is further supported by Simon Marsh, Surgical Director at 108 Harley Street, who notes that "Arthrosamid acts by forming a cushion between the exposed bony surfaces in the joint. This can reduce pain and improve function and lead to an improved quality of life."

This expertise has contributed significantly to establishing Arthrosamid as an innovative solution for knee osteoarthritis, particularly relevant given that approximately 8.5 million people in the UK (around 1 in 5 people aged over 45 in England) live with osteoarthritis.

Patient Stories

UK patients share positive experiences with Arthrosamid, highlighting improved mobility and pain relief.

Clinical data and real-world experiences demonstrate Arthrosamid's effectiveness in treating knee osteoarthritis. 

At the Essex clinic, patients consistently showed 50-100% improvement at the 4-month mark post-treatment, with no patients reporting zero response to the treatment.

Successful Outcomes 

Clinical studies have demonstrated Arthrosamid's effectiveness through a past study, which involved 49 participants with an average age of 70. 

The research tracked outcomes at 13, 26, and 52 weeks post-injection, showing that a single treatment with 6ml Arthrosamid remained effective after one year with good clinical effects and no significant adverse events. This study played a crucial role in securing Arthrosamid's European regulatory CE approval for knee osteoarthritis treatment in 2021.

Positive Aspects Highlighted

The treatment has demonstrated remarkable success across diverse patient profiles. One patient achieved complete pain freedom at 9 months post-treatment, while another regained full range of motion with no pain at 12 weeks, enabling their return to work. 

An Olympic athlete experienced significant mobility improvements and reduced discomfort during rigorous training, and a Harley Street GP reported remarkable improvements in daily activities and ability to maintain a demanding work schedule.

“I couldn’t believe how quick the procedure was, with very little discomfort and limited downtime. I was able to drive immediately. Pain can be really draining emotionally” she said. “Now, thanks to Arthrosamid®, I feel more able to do the things I love with less pain of it. I’m very glad I gave it a try.”

Treatment Timeline and Effectiveness

Patients may experience initial relief within 24 hours of treatment, though it typically takes 4-12 weeks to feel the maximum benefit. 

The full physiological changes in the synovium occur around 12 weeks post-treatment, though many patients report improvements by week 4. 

The treatment's effectiveness is supported by both human clinical trials (with documented benefits up to 3 years) and extensive safety data spanning two decades. As a non-degradable hydrogel, Arthrosamid is classified as an implant device, contributing to its long-lasting effects in the joint.

Cost and Accessibility in the UK

Price Range 

A single knee treatment typically costs up to £3,000, while treatment for both knees is between £5,000 and £6,000.*

In cases requiring top-up dosage, costs are around £2,300 for one knee and £4,300 for both knees. These prices reflect the treatment's long-lasting, single-injection approach, potentially offering better value compared to treatments requiring multiple doses over time.

Factors Affecting Cost Several factors influence the final treatment cost:

• The severity of knee OA condition

• Required dosage

• Clinic location

• Healthcare provider's expertise

• Additional costs for lab tests, medical supplies, and imaging (MRI or ultrasound) for needle guidance

*Note: The price ranges mentioned above are approximate and subject to change over time and across different locations. Costs may vary based on factors such as clinic pricing policies, the healthcare provider's experience, and evolving market conditions. It’s always advisable to check with individual providers for the most up-to-date pricing and availability.

Availability 

Arthrosamid injections are available at specialized clinics across the UK through qualified orthopedic surgeons and rheumatologists. The treatment has now been administered to over 10,000 patients across Europe. 

Why Not Try MSK Doctors for Expert Arthrosamid Care?

MSK Doctors specializes in Arthrosamid injections, offering expert care for long-lasting knee pain relief.

At MSK Doctors, we connect you with leading orthopaedic surgeons and sports medicine doctors who specialize in Arthrosamid treatments. 

Our team of qualified musculoskeletal specialists, led by Professor Paul Lee, takes a patient-centric approach, ensuring you receive personalized care that meets your specific needs. 

We combine cutting-edge technology with expert guidance to provide comprehensive evaluations and optimal treatment outcomes.

Comprehensive Support and Resources 

We provide extensive resources and support throughout your treatment process. Our platform offers detailed information about Arthrosamid, access to verified specialist profiles, and educational materials to help you make informed decisions about your care. 

With state-of-the-art facilities and advanced motion analysis technology, we ensure you receive the highest standard of care in your journey toward improved joint health. 

Contact MSK Doctors today to learn how Arthrosamid treatment could benefit your knee osteoarthritis and take the first step toward enhanced mobility and reduced pain.

Frequently Asked Questions (FAQ)

How long does it take to see results from Arthrosamid treatment? 

Most patients begin experiencing relief around 4 weeks post-treatment, with maximum benefits typically achieved between 4-12 weeks after injection.

How long do the effects of Arthrosamid last?

Clinical studies have shown benefits lasting up to 3 years, with the treatment being classified as a permanent implant as it cannot be broken down by the body.

Is Arthrosamid suitable for all types of arthritis? 

Arthrosamid is specifically designed for knee osteoarthritis and is not recommended for inflammatory arthritis conditions such as rheumatoid arthritis, psoriatic arthritis, or gout.

What is the success rate of Arthrosamid treatment?

Clinical data shows that 80% of patients experience significant improvement, with patients at the Essex clinic showing 50-100% improvement at the 4-month mark.

Why should I choose MSK Doctors for my Arthrosamid treatment? 

MSK Doctors, led by Professor Paul Lee, combines expert specialists and cutting-edge technology to deliver proven results, with documented success rates of 50-100% improvement in patients. Our state-of-the-art facilities and comprehensive support ensure optimal treatment outcomes with no GP referral required.